Finance

Beta
Lists
MAP:ASX
Microba Life Sciences Ltd
A$0.063
0.00%
(0.00) 1D
Jun 2, 2:14:40 PM GMT+10  ·   AUD
All symbols
SymbolPriceChange% Change
Generating top insights for MAP...
Mkt. cap
38.36M
Avg. vol.
405.75K
Volume
0.00
52-wk high
A$0.14
52-wk low
A$0.06
EPS
-A$0.04
Shares outstanding
608.96M
Mkt. cap
38.36M
Avg. vol.
405.75K
Volume
0.00
52-wk high
A$0.14
52-wk low
A$0.06
EPS
-A$0.04
Shares outstanding
608.96M
Analyst outlook
Analyst Ratings
Based on 2 analysts giving stock ratings to MAP in the past 3 months
Buy
Buy
2
Hold
0
Sell
0
12 month forecast
Based on 2 Wall Street analysts offering 12 month price targets for MAP in the last 3 months.
Highest
Current A$0.06
A$0.15 (+138.10%)
Average
A$0.14 (+122.22%)
Lowest
A$0.12 (+90.48%)
News stories
From sources across the web
About Microba Life Sciences Ltd
CEO-
Employees-
Founded2017
Headquarters-
SectorHealth care provider
Last report
Jan 28, 2026
Fiscal period
Q2 2026
EPS / Est. (AUD)
- / -
Revenue / Est. (AUD)
3.66M / -
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in AUD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in AUD
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
3.79M
3.79M
3.66M
3.66M
Cost of goods sold
1.99M
1.99M
1.98M
1.98M
Cost of revenue
1.99M
1.99M
1.98M
1.98M
Research and development expenses
626.46K
626.46K
142.04K
142.04K
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
6.04M
6.04M
5.06M
5.06M
Operating expense
8.61M
8.61M
7.13M
7.13M
Total operating expenses
10.59M
10.59M
9.11M
9.11M
Operating income
-6.80M
-6.80M
-5.45M
-5.45M
Other non operating income
-418.30K
-418.30K
658.46K
658.46K
EBT including unusual items
-4.58M
-4.58M
-5.40M
-5.40M
EBT excluding unusual items
-6.82M
-6.82M
-5.03M
-5.03M
Income tax expense
16.35K
16.35K
-125.26K
-125.26K
Effective tax rate
-0.36%
-0.36%
2.32%
2.32%
Other operating expenses
821.43K
821.43K
828.78K
828.78K
Net income
-4.60M
-4.60M
-5.28M
-5.28M
Net profit margin
-121.26%
-121.26%
-144.21%
-144.21%
Earnings per share
-
-
-
-
Interest and investment income
108.94K
108.94K
105.25K
105.25K
Interest expense
-47.76K
-47.76K
-44.59K
-44.59K
Net interest expenses
61.17K
61.17K
60.66K
60.66K
Depreciation and amortization charges
1.13M
1.13M
1.10M
1.10M
EBITDA
-6.47M
-6.47M
-4.70M
-4.70M
Gain or loss from assets sale
922.00
922.00
-
-
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more